We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WINT
5751
DELISTED
Windtree Therapeutics
WINT
$153K ﹤0.01%
+1
New +$97.3K
XGN icon
5752
Exagen
XGN
$109M
$153K ﹤0.01%
+10,189
New +$156K
BTMDW
5753
DELISTED
Biote Corp. Warrant
BTMDW
$153K ﹤0.01%
+157,815
New +$136K
POLA icon
5754
Polar Power
POLA
$5.93M
$151K ﹤0.01%
+2,303
New +$169K
HLAHU
5755
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Unit
HLAHU
$151K ﹤0.01%
15,000
-33,327
-69% -$334K
AVPT icon
5756
AvePoint
AVPT
$2.76B
$149K ﹤0.01%
+12,170
New +$133K
IMUX icon
5757
Immunic
IMUX
$190M
$149K ﹤0.01%
+1,213
New +$168K
TLPH icon
5758
Talphera
TLPH
$66.4M
$149K ﹤0.01%
5,397
-4,563
-46% -$122K
AXIA
5759
AXIA Energia
AXIA
$23.9B
$148K ﹤0.01%
21,612
-26,650
-55% -$163K
VIST icon
5760
Vista Energy
VIST
$7.84B
$148K ﹤0.01%
36,162
-20,825
-37% -$66.6K
HFFG icon
5761
HF Foods Group
HFFG
$80.2M
$147K ﹤0.01%
27,858
-3,870
-12% -$24.1K
CSCI
5762
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$147K ﹤0.01%
+1,671
New +$159K
FUSN
5763
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$147K ﹤0.01%
18,221
+4,149
+29% +$35.7K
PCTI
5764
DELISTED
PCTEL, Inc. Common Stock
PCTI
$146K ﹤0.01%
22,332
-15,352
-41% -$103K
OPTN
5765
DELISTED
OptiNose
OPTN
$143K ﹤0.01%
3,069
-1,996
-39% -$102K
WPF
5766
DELISTED
Foley Trasimene Acquisition Corp.
WPF
$143K ﹤0.01%
14,673
-467,004
-97% -$4.74M
SBEAW
5767
DELISTED
SilverBox Engaged Merger Corp I Warrant
SBEAW
$142K ﹤0.01%
+183,908
New +$132K
CYCN icon
5768
Cyclerion Therapeutics
CYCN
$14.9M
$141K ﹤0.01%
1,816
-187
-9% -$11.7K
LRMR icon
5769
Larimar Therapeutics
LRMR
$397M
$141K ﹤0.01%
+14,314
New +$162K
YARW
5770
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$141K ﹤0.01%
44
-6
-12% -$23.7K
IMMP
5771
Immutep
IMMP
$56.3M
$140K ﹤0.01%
+36,282
New +$144K
VIOT
5772
Viomi Technology
VIOT
$51.8M
$138K ﹤0.01%
16,309
-22,147
-58% -$180K
VTSI icon
5773
VirTra
VTSI
$34.9M
$138K ﹤0.01%
+18,724
New +$110K
MITO
5774
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$138K ﹤0.01%
+88,426
New +$123K
IGC icon
5775
IGC Pharma
IGC
$26M
$137K ﹤0.01%
83,260

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.